2026 · 1st Quarter (Jan 1 - Mar 31)

CHATTEM, INC. DBA OPELLA

Filed by AKIN GUMP STRAUSS HAUER & FELD.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 20, 2026
Income: $70,000.00
Expenses: Not reported
Registrant: AKIN GUMP STRAUSS HAUER & FELD
Client: CHATTEM, INC. DBA OPELLA
Filing UUID: 073d4026-0f55-483e-ae9f-76ea38a16f94
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments H.R. 4273/S. 2292; S. 2529 - The SMART OTC Act; Division F, Title V of The Continuing Appropriations and Extensions Act, 2026 - H.R. 5371; Issues related to consumer health care products supply chain; Issues related to FY2027 appropriations report language.

Literal federal measure citations: H.R. 4273, S. 2292, S. 2529, H.R. 5371

TRD · Trade (domestic/foreign)

Issues related to imports of unavailable natural resources.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.